Alternatives
Alternatives to Daliresp 250 mcg tablet
1 other presentations of Roflumilast 250 mcg tablet
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Roflumilast), strength (250 mcg) and dosage form (tablet) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Daliresp 250 mcg tabletThis pageOral | AstraZeneca Pharmaceuticals | US FDA | 1 blister pack, 10 blister pack | Store DALIRESP tablets at 20° - 25°C (68° - 77°F), excursions permitted to 15° - 30°C (59° - 86°F). | On request | — | Available on request |
| Roflumilast 250 mcg tabletOral | — | US FDA | 1 blister pack, 2 blister pack | Store roflumilast tablets at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Storage and Handling | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Daliresp 250 mcg tabletNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.